UniProt ID | ESR1_MOUSE | |
---|---|---|
UniProt AC | P19785 | |
Protein Name | Estrogen receptor | |
Gene Name | Esr1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 599 | |
Subcellular Localization | Nucleus . Cytoplasm. Golgi apparatus. Cell membrane. Colocalizes with ZDHHC7 and ZDHHC21 in the Golgi apparatus where most probably palmitoylation occurs. Associated with the plasma membrane when palmitoylated.. | |
Protein Description | Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3.. | |
Protein Sequence | MTMTLHTKASGMALLHQIQGNELEPLNRPQLKMPMERALGEVYVDNSKPTVFNYPEGAAYEFNAAAAAAAAASAPVYGQSGIAYGPGSEAAAFSANSLGAFPQLNSVSPSPLMLLHPPPQLSPFLHPHGQQVPYYLENEPSAYAVRDTGPPAFYRSNSDNRRQNGRERLSSSNEKGNMIMESAKETRYCAVCNDYASGYHYGVWSCEGCKAFFKRSIQGHNDYMCPATNQCTIDKNRRKSCQACRLRKCYEVGMMKGGIRKDRRGGRMLKHKRQRDDLEGRNEMGASGDMRAANLWPSPLVIKHTKKNSPALSLTADQMVSALLDAEPPMIYSEYDPSRPFSEASMMGLLTNLADRELVHMINWAKRVPGFGDLNLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHRRLAQLLLILSHIRHMSNKGMEHLYNMKCKNVVPLYDLLLEMLDAHRLHAPASRMGVPPEEPSQTQLATTSSTSAHSLQTYYIPPEAEGFPNTI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | O-linked_Glycosylation | MTLHTKASGMALLHQ CEEECHHHHHHHHHH | 30.56 | 8999954 | |
50 | O-linked_Glycosylation | YVDNSKPTVFNYPEG EECCCCCCEECCCCC | 41.27 | 8999954 | |
108 | Phosphorylation | FPQLNSVSPSPLMLL CCCCCCCCCCCEEEC | 21.34 | - | |
110 | Phosphorylation | QLNSVSPSPLMLLHP CCCCCCCCCEEECCC | 24.14 | - | |
122 | Phosphorylation | LHPPPQLSPFLHPHG CCCCCCCCCCCCCCC | 14.36 | 14647453 | |
156 | Phosphorylation | GPPAFYRSNSDNRRQ CCCCCCCCCCCCCCC | 29.34 | 8541227 | |
158 | Phosphorylation | PAFYRSNSDNRRQNG CCCCCCCCCCCCCCH | 37.19 | 8541227 | |
171 | Phosphorylation | NGRERLSSSNEKGNM CHHHHHCCCCHHCCC | 41.60 | 14647453 | |
216 | Phosphorylation | CKAFFKRSIQGHNDY HHHHHHHHHCCCCCC | 21.61 | - | |
264 | Asymmetric dimethylarginine | GGIRKDRRGGRMLKH CCCCCCCCCCCCCCC | 63.15 | - | |
264 | Methylation | GGIRKDRRGGRMLKH CCCCCCCCCCCCCCC | 63.15 | - | |
287 | Phosphorylation | GRNEMGASGDMRAAN CCCCCCCCCCCCHHH | 29.60 | - | |
298 | Phosphorylation | RAANLWPSPLVIKHT CHHHCCCCCEEEEEC | 21.20 | 8541227 | |
451 | S-palmitoylation | LQGEEFVCLKSIILL CCCCCEEEEEEEHHH | 4.87 | 22031296 | |
464 | Phosphorylation | LLNSGVYTFLSSTLK HHCCCHHHHHHHHHH | 18.72 | - | |
468 | Phosphorylation | GVYTFLSSTLKSLEE CHHHHHHHHHHHHHH | 39.65 | - | |
541 | Phosphorylation | CKNVVPLYDLLLEML CCCCCHHHHHHHHHH | 9.85 | - | |
575 | O-linked_Glycosylation | SQTQLATTSSTSAHS CCCCEECCCCCCCCE | 18.31 | 8999954 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
108 | S | Phosphorylation | Kinase | CDK2 | P97377 | Uniprot |
110 | S | Phosphorylation | Kinase | CDK2 | P97377 | Uniprot |
171 | S | Phosphorylation | Kinase | RPS6KB1 | Q8BSK8 | GPS |
171 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
216 | S | Phosphorylation | Kinase | PRKCA | P20444 | GPS |
309 | S | Phosphorylation | Kinase | PAK1 | O88643 | GPS |
541 | Y | Phosphorylation | Kinase | TYR-KINASES | - | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | Stub1 | Q9WUD1 | PMID:22199232 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
122 | S | Phosphorylation |
| - |
264 | R | Methylation |
| - |
264 | R | Methylation |
| - |
451 | C | Palmitoylation |
| 22031296 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ESR1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SMCE1_HUMAN | SMARCE1 | physical | 12145209 | |
JUN_MOUSE | Jun | physical | 19605792 | |
NCOA2_MOUSE | Ncoa2 | physical | 20211142 | |
PO4F1_MOUSE | Pou4f1 | physical | 20211142 | |
PO4F2_MOUSE | Pou4f2 | physical | 20211142 | |
SMCE1_HUMAN | SMARCE1 | physical | 16769725 | |
KDM4B_MOUSE | Kdm4b | physical | 21445275 | |
LEF1_MOUSE | Lef1 | physical | 18202148 | |
TF7L1_MOUSE | Tcf7l1 | physical | 18202148 | |
CTNB1_MOUSE | Ctnnb1 | physical | 18202148 | |
STA5A_MOUSE | Stat5a | physical | 15304355 | |
SRC_MOUSE | Src | physical | 17921256 | |
NOS3_MOUSE | Nos3 | physical | 17921256 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
O-linked Glycosylation | |
Reference | PubMed |
"Glycosylation of the murine estrogen receptor-alpha."; Cheng X., Hart G.W.; J. Steroid Biochem. Mol. Biol. 75:147-158(2000). Cited for: GLYCOSYLATION AT SER-10; THR-50 AND THR-575. | |
"A subpopulation of estrogen receptors are modified by O-linked N-acetylglucosamine."; Jiang M.S., Hart G.W.; J. Biol. Chem. 272:2421-2428(1997). Cited for: GLYCOSYLATION AT THR-575. | |
Palmitoylation | |
Reference | PubMed |
"DHHC-7 and -21 are palmitoylacyltransferases for sex steroidreceptors."; Pedram A., Razandi M., Deschenes R.J., Levin E.R.; Mol. Biol. Cell 23:188-199(2012). Cited for: PALMITOYLATION AT CYS-451, AND MUTAGENESIS OF CYS-451. |